• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bmi1 抑制 Noxa 表达促进去癸醇诱导非小细胞肺癌细胞凋亡

Repression of Noxa by Bmi1 contributes to deguelin-induced apoptosis in non-small cell lung cancer cells.

机构信息

Department of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.

Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.

出版信息

J Cell Mol Med. 2018 Dec;22(12):6213-6227. doi: 10.1111/jcmm.13908. Epub 2018 Sep 25.

DOI:10.1111/jcmm.13908
PMID:30255595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6237602/
Abstract

Deguelin, a natural rotenoid isolated from several plants, has been reported to exert anti-tumour effects in various cancers. However, the molecular mechanism of this regulation remains to be fully elucidated. Here, we found that deguelin inhibited the growth of non-small cell lung cancer (NSCLC) cells both in vitro and in vivo by downregulation of Bmi1 expression. Our data showed that Bmi1 is highly expressed in human NSCLC tissues and cell lines. Knockdown of Bmi1 significantly suppressed NSCLC cell proliferation and colony formation. Deguelin treatment attenuated the binding activity of Bmi1 to the Noxa promoter, thus resulting in Noxa transcription and apoptosis activation. Knockdown of Bmi1 promoted Noxa expression and enhanced deguelin-induced apoptosis, whereas overexpression of Bmi1 down-regulated Noxa protein level and deguelin-induced apoptosis. Overall, our study demonstrated a novel apoptotic mechanism for deguelin to exert its anti-tumour activity in NSCLC cells.

摘要

裂环烯醚萜类化合物 deguelin 是从多种植物中分离得到的天然倍半萜,已被报道具有多种抗癌作用。然而,其调控机制仍有待充分阐明。本研究发现,deguelin 通过下调 Bmi1 表达,在体外和体内均能抑制非小细胞肺癌(NSCLC)细胞的生长。研究数据显示,Bmi1 在人 NSCLC 组织和细胞系中高表达。Bmi1 敲低显著抑制 NSCLC 细胞增殖和集落形成。deguelin 处理可减弱 Bmi1 与 Noxa 启动子的结合活性,从而导致 Noxa 转录和凋亡激活。Bmi1 敲低促进 Noxa 表达并增强 deguelin 诱导的细胞凋亡,而过表达 Bmi1 则下调 Noxa 蛋白水平并抑制 deguelin 诱导的细胞凋亡。总之,本研究揭示了 deguelin 在 NSCLC 细胞中发挥抗肿瘤活性的一种新的凋亡机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/e411eeb5b1ca/JCMM-22-6213-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/3e998d03ab4b/JCMM-22-6213-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/ea6577da6b19/JCMM-22-6213-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/4780615e2afa/JCMM-22-6213-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/b1ecf5286c30/JCMM-22-6213-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/59a706c581cd/JCMM-22-6213-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/e411eeb5b1ca/JCMM-22-6213-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/3e998d03ab4b/JCMM-22-6213-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/ea6577da6b19/JCMM-22-6213-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/4780615e2afa/JCMM-22-6213-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/b1ecf5286c30/JCMM-22-6213-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/59a706c581cd/JCMM-22-6213-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a23c/6237602/e411eeb5b1ca/JCMM-22-6213-g006.jpg

相似文献

1
Repression of Noxa by Bmi1 contributes to deguelin-induced apoptosis in non-small cell lung cancer cells.Bmi1 抑制 Noxa 表达促进去癸醇诱导非小细胞肺癌细胞凋亡
J Cell Mol Med. 2018 Dec;22(12):6213-6227. doi: 10.1111/jcmm.13908. Epub 2018 Sep 25.
2
Deguelin attenuates non-small cell lung cancer cell metastasis through inhibiting the CtsZ/FAK signaling pathway.地榆苷通过抑制 CtsZ/FAK 信号通路抑制非小细胞肺癌细胞转移。
Cell Signal. 2018 Oct;50:131-141. doi: 10.1016/j.cellsig.2018.07.001. Epub 2018 Jul 7.
3
Deguelin inhibits epithelial-to-mesenchymal transition and metastasis of human non-small cell lung cancer cells by regulating NIMA-related kinase 2.德古醇通过调节 NIMA 相关激酶 2 抑制人非小细胞肺癌细胞上皮-间充质转化和转移。
Thorac Cancer. 2017 Jul;8(4):320-327. doi: 10.1111/1759-7714.12444. Epub 2017 May 16.
4
Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells.鱼藤素诱导人支气管上皮细胞中环氧合酶-2表达的抑制作用。
Clin Cancer Res. 2004 Feb 1;10(3):1074-9. doi: 10.1158/1078-0432.ccr-0833-3.
5
Deguelin exerts anticancer activity of human gastric cancer MGC-803 and MKN-45 cells in vitro.地榆苷在体外对人胃癌 MGC-803 和 MKN-45 细胞具有抗癌活性。
Int J Mol Med. 2018 Jun;41(6):3157-3166. doi: 10.3892/ijmm.2018.3532. Epub 2018 Mar 5.
6
Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.AMP激活的蛋白激酶和Akt调节的生存素在鱼藤素肺癌化学预防活性中的作用
Cancer Res. 2007 Dec 15;67(24):11630-9. doi: 10.1158/0008-5472.CAN-07-2401.
7
Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice.地榆苷,一种 Akt 抑制剂,可下调 NF-κB 信号通路并诱导结肠癌细胞凋亡,抑制小鼠肿瘤生长。
Dig Dis Sci. 2012 Nov;57(11):2873-82. doi: 10.1007/s10620-012-2237-x. Epub 2012 May 24.
8
Deguelin Induces the Apoptosis of Lung Squamous Cell Carcinoma Cells through Regulating the Expression of Galectin-1.鱼藤素通过调节半乳糖凝集素-1的表达诱导肺鳞状细胞癌细胞凋亡。
Int J Biol Sci. 2016 May 25;12(7):850-60. doi: 10.7150/ijbs.14773. eCollection 2016.
9
Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway.去氢骆驼蓬碱通过靶向糖原合成激酶-3β/β-连环蛋白通路抑制人前列腺癌细胞增殖和迁移的作用研究
Int J Cancer. 2011 Dec 15;129(12):2916-27. doi: 10.1002/ijc.25949. Epub 2011 Apr 7.
10
Antitumor effects of deguelin on H460 human lung cancer cells in vitro and in vivo: Roles of apoptotic cell death and H460 tumor xenografts model.鱼藤素对人H460肺癌细胞的体内外抗肿瘤作用:凋亡性细胞死亡及H460肿瘤异种移植模型的作用
Environ Toxicol. 2017 Jan;32(1):84-98. doi: 10.1002/tox.22214. Epub 2015 Nov 23.

引用本文的文献

1
Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway.鱼藤素通过抑制表皮生长因子受体(EGFR)信号通路恢复耐紫杉醇卵巢癌细胞对紫杉醇的敏感性。
Cancer Manag Res. 2024 May 28;16:507-525. doi: 10.2147/CMAR.S457221. eCollection 2024.
2
TRAF4 regulates ubiquitination-modulated survivin turnover and confers radioresistance.TRAF4 调节泛素化修饰的 survivin 降解并赋予放射抵抗性。
Int J Biol Sci. 2024 Jan 1;20(1):182-199. doi: 10.7150/ijbs.87180. eCollection 2024.
3
Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer.

本文引用的文献

1
Deguelin suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-c-Met pathway.鱼藤素通过靶向HGF-c-Met信号通路抑制人肝癌血管生成。
Oncotarget. 2017 Oct 26;9(1):152-166. doi: 10.18632/oncotarget.22077. eCollection 2018 Jan 2.
2
Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma.德古醇,一种 Aurora B 激酶抑制剂,在人食管鳞癌细胞中表现出强大的抗肿瘤作用。
EBioMedicine. 2017 Dec;26:100-111. doi: 10.1016/j.ebiom.2017.10.030. Epub 2017 Nov 3.
3
Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.
丹参酮IIA靶向Survivin抑制结直肠癌肿瘤生长并克服化疗耐药性。
Cell Death Discov. 2023 Sep 25;9(1):351. doi: 10.1038/s41420-023-01622-8.
4
Survivin degradation by bergenin overcomes pemetrexed resistance.小檗因降解生存素克服培美曲塞耐药性。
Cell Oncol (Dordr). 2023 Dec;46(6):1837-1853. doi: 10.1007/s13402-023-00850-5. Epub 2023 Aug 5.
5
Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells.Skp2 介导的 MLKL 降解赋予非小细胞肺癌细胞顺铂耐药性。
Commun Biol. 2023 Aug 2;6(1):805. doi: 10.1038/s42003-023-05166-6.
6
Dioscin inhibiting EGFR-mediated Survivin expression promotes apoptosis in oral squamous cell carcinoma cells.薯蓣皂苷抑制EGFR介导的Survivin表达促进口腔鳞状细胞癌细胞凋亡。
J Cancer. 2023 Jul 9;14(11):2027-2038. doi: 10.7150/jca.85011. eCollection 2023.
7
Recent progress in targeted therapy for non-small cell lung cancer.非小细胞肺癌靶向治疗的最新进展
Front Pharmacol. 2023 Feb 21;14:1125547. doi: 10.3389/fphar.2023.1125547. eCollection 2023.
8
BMI1 induces ubiquitination and protein degradation of Nod-like receptor family CARD domain containing 5 and suppresses human leukocyte antigen class I expression to induce immune escape in non-small cell lung cancer.BMI1诱导含CARD结构域的Nod样受体家族成员5的泛素化和蛋白质降解,并抑制人类白细胞抗原I类分子的表达,从而在非小细胞肺癌中诱导免疫逃逸。
Kaohsiung J Med Sci. 2022 Dec;38(12):1190-1202. doi: 10.1002/kjm2.12602. Epub 2022 Oct 4.
9
Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease.库欣病中,通过调节诺克斯(noxa)逃避细胞凋亡,导致垂体腺瘤的发生。
Cell Rep. 2022 Aug 23;40(8):111223. doi: 10.1016/j.celrep.2022.111223.
10
Epithelial-mesenchymal reprogramming by KLF4-regulated Rictor expression contributes to metastasis of non-small cell lung cancer cells.KLF4 调控的 Rictor 表达引起的上皮-间充质重编程促进非小细胞肺癌细胞的转移。
Int J Biol Sci. 2022 Jul 18;18(13):4869-4883. doi: 10.7150/ijbs.73548. eCollection 2022.
鱼藤素通过下调己糖激酶II介导的糖酵解来抑制非小细胞肺癌。
Oncotarget. 2017 May 16;8(20):32586-32599. doi: 10.18632/oncotarget.15937.
4
BAD, a Proapoptotic Protein, Escapes ERK/RSK Phosphorylation in Deguelin and siRNA-Treated HeLa Cells.促凋亡蛋白BAD在鱼藤素和经小干扰RNA处理的HeLa细胞中逃避细胞外信号调节激酶/核糖体S6激酶磷酸化作用。
PLoS One. 2016 Jan 8;11(1):e0145780. doi: 10.1371/journal.pone.0145780. eCollection 2016.
5
BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance.BMI1在黑色素瘤中诱导一种侵袭性特征,促进转移和化疗耐药性。
Genes Dev. 2016 Jan 1;30(1):18-33. doi: 10.1101/gad.267757.115. Epub 2015 Dec 17.
6
3,6,2',4',5'-Pentahydroxyflavone, an orally bioavailable multiple protein kinase inhibitor, overcomes gefitinib resistance in non-small cell lung cancer.3,6,2',4',5'-五羟基黄酮是一种口服生物可利用的多蛋白激酶抑制剂,可克服非小细胞肺癌中的吉非替尼耐药性。
J Biol Chem. 2014 Oct 10;289(41):28192-201. doi: 10.1074/jbc.M114.593475. Epub 2014 Aug 13.
7
Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells.Usp9x和Noxa介导的Mcl-1下调促成培美曲塞诱导的人非小细胞肺癌细胞凋亡。
Cell Death Dis. 2014 Jul 3;5(7):e1316. doi: 10.1038/cddis.2014.281.
8
A derivative of chrysin suppresses two-stage skin carcinogenesis by inhibiting mitogen- and stress-activated kinase 1.白杨素衍生物通过抑制有丝分裂原和应激激活激酶 1 抑制二阶段皮肤癌变。
Cancer Prev Res (Phila). 2014 Jan;7(1):74-85. doi: 10.1158/1940-6207.CAPR-13-0133. Epub 2013 Oct 29.
9
Bmi1 is required for tumorigenesis in a mouse model of intestinal cancer.BMI1 是肠道癌小鼠模型肿瘤发生所必需的。
Oncogene. 2014 Jul 10;33(28):3742-7. doi: 10.1038/onc.2013.333. Epub 2013 Aug 19.
10
Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.BMI1和微小RNA-16的失调共同作用,增强难治性套细胞淋巴瘤侧群细胞的抗凋亡潜能。
Oncogene. 2014 Apr 24;33(17):2191-203. doi: 10.1038/onc.2013.177. Epub 2013 May 20.